Ironwood Investment Counsel LLC Acquires 11,465 Shares of Amdocs Limited $DOX

Ironwood Investment Counsel LLC increased its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 35.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 43,651 shares of the technology company’s stock after purchasing an additional 11,465 shares during the period. Ironwood Investment Counsel LLC’s holdings in Amdocs were worth $3,514,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DOX. Alliancebernstein L.P. boosted its stake in shares of Amdocs by 32.1% during the third quarter. Alliancebernstein L.P. now owns 2,359,779 shares of the technology company’s stock valued at $193,620,000 after purchasing an additional 573,349 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Amdocs by 500.0% during the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 420,000 shares of the technology company’s stock valued at $34,461,000 after purchasing an additional 350,000 shares in the last quarter. Arbejdsmarkedets Tillaegspension bought a new position in shares of Amdocs during the fourth quarter valued at approximately $24,272,000. AQR Capital Management LLC boosted its stake in shares of Amdocs by 25.9% during the third quarter. AQR Capital Management LLC now owns 1,368,944 shares of the technology company’s stock valued at $111,309,000 after purchasing an additional 281,476 shares in the last quarter. Finally, Millennium Management LLC boosted its stake in shares of Amdocs by 1,500.6% during the third quarter. Millennium Management LLC now owns 295,800 shares of the technology company’s stock valued at $24,270,000 after purchasing an additional 277,320 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

Trending Headlines about Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs beat quarterly earnings estimates with EPS of $1.78 and matched revenue expectations at $1.17 billion, while revenue still rose 3.9% year over year. Amdocs earnings release and conference call
• Positive Sentiment: Management lifted fiscal 2026 guidance, signaling confidence in continued growth and profitability after the quarter. Zacks on Amdocs Q2 earnings
• Positive Sentiment: The company highlighted progress in GenAI and “agentic telco” initiatives, including launching Telco Agents in Google’s Gemini Enterprise marketplace. Amdocs Telco Agents announcement
• Positive Sentiment: Several new customer wins and platform expansions were announced, including deals with Lumen, Vodafone Ireland, Telefónica Móviles Argentina, and Qué tal Móvil, supporting backlog and long-term demand. Lumen and Amdocs cloud migration announcement
• Neutral Sentiment: Amdocs also announced its third-quarter investor conference schedule, which is routine investor-relations news rather than a direct business catalyst. Amdocs investor conference schedule
• Neutral Sentiment: The board declared a quarterly dividend, which is supportive for income investors but not likely the main driver of trading today.

Analysts Set New Price Targets

A number of research firms have recently issued reports on DOX. Weiss Ratings reiterated a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday. Stifel Nicolaus lowered their target price on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research note on Thursday. Barclays lowered their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Finally, Cfra downgraded shares of Amdocs to a “sell” rating in a research note on Thursday. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $86.67.

Amdocs Price Performance

Shares of DOX opened at $60.58 on Monday. The company has a market cap of $6.54 billion, a price-to-earnings ratio of 12.12, a price-to-earnings-growth ratio of 0.93 and a beta of 0.40. Amdocs Limited has a twelve month low of $59.40 and a twelve month high of $95.41. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. The company has a 50 day moving average of $65.25 and a two-hundred day moving average of $73.48.

Amdocs (NASDAQ:DOX) last announced its earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.01. The company had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.67%. Amdocs’s revenue was up 3.9% compared to the same quarter last year. During the same period last year, the firm earned $1.78 earnings per share. As a group, analysts predict that Amdocs Limited will post 7.41 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a $0.569 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.8%. Amdocs’s dividend payout ratio (DPR) is currently 45.60%.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.